Rubenstein M H, Harrell L C, Sheynberg B V, Schunkert H, Bazari H, Palacios I F
Cardiac Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.
Circulation. 2000 Dec 12;102(24):2966-72. doi: 10.1161/01.cir.102.24.2966.
Patients with end-stage renal disease undergoing conventional balloon angioplasty have reduced procedural success and increased complication rates. This study was designed to determine the immediate and long-term outcomes of patients with varying degrees of renal failure undergoing percutaneous coronary intervention in the current device era.
We compared the immediate and long-term outcomes of 362 renal failure patients (creatinine >1.5 mg/dL) with those of 2972 patients with normal renal function who underwent percutaneous coronary intervention between 1994 and 1997. Patients with renal failure were older and had more associated comorbidities. They had reduced procedural success (89.5% versus 92.9%, P:=0.007) and greater in-hospital combined major event (death, Q-wave myocardial infarction, emergent CABG; 10.8% versus 1.8%; P:<0.0001) rates. Renal failure was an independent predictor of major adverse cardiac events (MACEs) (OR, 3.41; 95% CI, 1.84 to 6.22; P:<0.00001). Logistic regression analysis identified shock, peripheral vascular disease, balloon angioplasty strategy, and unstable angina as independent predictors of in-hospital MACEs in the renal group. Compared with 362 age- and sex-matched patients selected from the control group, patients with renal failure had a lower survival rate (27.7% versus 6.1%, P:<0.0001) and a greater MACE rate (51% versus 33%, P:<0.001) at long-term follow-up. Cox regression analysis identified age and PTCA strategy as independent predictors of long-term MACEs in the renal group. Finally, within the renal failure population, the dialysis and nondialysis patients experienced remarkably similar immediate and long-term outcomes.
Although patients with renal failure can be treated with a high procedural success rate in the new device era, they have an increased rate of major events both in hospital and at long-term follow-up. Nevertheless, utilization of stenting and debulking techniques improves immediate and long-term outcomes.
接受传统球囊血管成形术的终末期肾病患者手术成功率降低,并发症发生率升高。本研究旨在确定在当前器械时代,不同程度肾功能衰竭患者接受经皮冠状动脉介入治疗的近期和长期结果。
我们比较了1994年至1997年间362例肾功能衰竭患者(肌酐>1.5mg/dL)与2972例肾功能正常患者接受经皮冠状动脉介入治疗的近期和长期结果。肾功能衰竭患者年龄更大,合并症更多。他们的手术成功率降低(89.5%对92.9%,P=0.007),住院期间主要联合事件(死亡、Q波心肌梗死、急诊冠状动脉搭桥术;10.8%对1.8%;P<0.0001)发生率更高。肾功能衰竭是主要不良心脏事件(MACE)的独立预测因素(OR,3.41;95%CI,1.84至6.22;P<0.00001)。逻辑回归分析确定休克、外周血管疾病、球囊血管成形术策略和不稳定型心绞痛是肾组住院期间MACE的独立预测因素。与从对照组中选出的362例年龄和性别匹配的患者相比,肾功能衰竭患者在长期随访中的生存率更低(27.7%对6.1%,P<0.0001),MACE发生率更高(51%对33%,P<0.001)。Cox回归分析确定年龄和经皮冠状动脉腔内血管成形术(PTCA)策略是肾组长期MACE的独立预测因素。最后,在肾功能衰竭人群中,透析患者和非透析患者的近期和长期结果非常相似。
尽管在新器械时代肾功能衰竭患者可以获得较高的手术成功率,但他们在住院期间和长期随访中的主要事件发生率均升高。然而,支架置入和减容技术的应用改善了近期和长期结果。